251 related articles for article (PubMed ID: 1186822)
1. Prostaglandins as mediators of hypercalcemia associated with certain types of cancer.
Seyberth HW; Segre GV; Morgan JL; Sweetman BJ; Potts JT; Oates JA
N Engl J Med; 1975 Dec; 293(25):1278-83. PubMed ID: 1186822
[TBL] [Abstract][Full Text] [Related]
2. Editorial: Prostaglandins, hypercalcemia and cancer.
Tashjian AH
N Engl J Med; 1975 Dec; 293(25):1317-8. PubMed ID: 1186828
[No Abstract] [Full Text] [Related]
3. Plasma prostaglandin E in patients with cancer with and without hypercalcemia.
Robertson RP; Baylink DJ; Metz SA; Cummings KB
J Clin Endocrinol Metab; 1976 Dec; 43(6):1330-5. PubMed ID: 1002818
[TBL] [Abstract][Full Text] [Related]
4. Biochemical evaluation of patients with cancer-associated hypercalcemia: evidence for humoral and nonhumoral groups.
Stewart AF; Horst R; Deftos LJ; Cadman EC; Lang R; Broadus AE
N Engl J Med; 1980 Dec; 303(24):1377-83. PubMed ID: 6253785
[TBL] [Abstract][Full Text] [Related]
5. Contribution of parathyroid hormone-related peptide to the evaluation of hypercalcemia.
Audran M; Minebois-Villégas A; Lortholary A; Legrand E; Pascaretti C; Giraud P; Subra JF; Boasson M; Jallet P
Rev Rhum Engl Ed; 1995 Mar; 62(3):189-96. PubMed ID: 7788336
[TBL] [Abstract][Full Text] [Related]
6. Prostaglandins, calcium metabolism and cancer.
Tashjian AH; Voelkel EF; Goldhaber P; Levine L
Fed Proc; 1974 Jan; 33(1):81-6. PubMed ID: 4203957
[No Abstract] [Full Text] [Related]
7. Characterization of the group of patients with the hypercalcemia of cancer who respond to treatment with prostaglandin synthesis inhibitors.
Seyberth HW; Segre GV; Hamet P; Sweetman BJ; Potts JT; Oates JA
Trans Assoc Am Physicians; 1976; 89():92-104. PubMed ID: 190750
[No Abstract] [Full Text] [Related]
8. Prostaglandin E production and hypercalcaemia in rats bearing the Walker carcinosarcoma.
Seyberth HW; Bonsch G; Müller H; Minne HW; Erlenmaier T; Strein K; Imbeck H; Mrongovius R
Br J Cancer; 1980 Sep; 42(3):455-61. PubMed ID: 7426347
[TBL] [Abstract][Full Text] [Related]
9. Urinary excretion of parathyroid hormone-related protein as a predictor of hypercalcemia in patients with adult T-cell leukemia.
Imamura H; Koreeda Y; Okadome T; Tara M; Niina K; Shizume K; Ohsumi K; Sato K
Jpn J Clin Oncol; 1992 Oct; 22(5):325-30. PubMed ID: 1469794
[TBL] [Abstract][Full Text] [Related]
10. Stimulation of calcium reabsorption observed in advanced breast cancer patients with hypercalcemia and multiple bone metastases.
Kimura S; Adchi I; Yamaguchi K; Suzuki M; Shimada A; Sato Y; Nagaoka K; Abe K
Jpn J Cancer Res; 1985 Apr; 76(4):308-14. PubMed ID: 2989061
[TBL] [Abstract][Full Text] [Related]
11. Proceedings: Elevated prostaglandin synthesis and its inhibition in the hypercalcemia associated with solid tumors.
Seyberth HW; Oates JA
Arzneimittelforschung; 1976; 26(6):1271-2. PubMed ID: 989465
[No Abstract] [Full Text] [Related]
12. Aspirin inhibition of 1 alpha-hydroxyvitamin D3 or parathyroid hormone induced hypercalcemia in vivo in rats. A mechanism independent of prostaglandin biosynthesis inhibition.
Kawashima H; Kurozumi S; Hashimoto Y
Biochem Pharmacol; 1985 Jun; 34(11):1901-6. PubMed ID: 4004906
[TBL] [Abstract][Full Text] [Related]
13. Prostaglandins and hypercalcemia of cancer.
Robertson RP
Med Clin North Am; 1981 Jul; 65(4):845-53. PubMed ID: 7278429
[No Abstract] [Full Text] [Related]
14. Immunochemical characterization of circulating parathyroid hormone-related protein in patients with humoral hypercalcemia of cancer.
Burtis WJ; Brady TG; Orloff JJ; Ersbak JB; Warrell RP; Olson BR; Wu TL; Mitnick ME; Broadus AE; Stewart AF
N Engl J Med; 1990 Apr; 322(16):1106-12. PubMed ID: 2320080
[TBL] [Abstract][Full Text] [Related]
15. Absence of parathyroid hormone messenger RNA in nonparathyroid tumors associated with hypercalcemia.
Simpson EL; Mundy GR; D'Souza SM; Ibbotson KJ; Bockman R; Jacobs JW
N Engl J Med; 1983 Aug; 309(6):325-30. PubMed ID: 6866067
[TBL] [Abstract][Full Text] [Related]
16. Hypercalcemic factors other than parathyroid hormone-related protein.
Mundy GR
Endocrinol Metab Clin North Am; 1989 Sep; 18(3):795-806. PubMed ID: 2673774
[TBL] [Abstract][Full Text] [Related]
17. Disodium pamidronate in the preoperative treatment of hypercalcemia in patients with primary hyperparathyroidism.
Jansson S; Tisell LE; Lindstedt G; Lundberg PA
Surgery; 1991 Sep; 110(3):480-6. PubMed ID: 1845370
[TBL] [Abstract][Full Text] [Related]
18. Failure of indomethacin to reduce hypercalcemia in patients with breast cancer.
Coombes RC; Neville AM; Bondy PK; Powles TJ
Prostaglandins; 1976 Dec; 12(6):1027-35. PubMed ID: 1005735
[TBL] [Abstract][Full Text] [Related]
19. Hypercalcemia of malignancy: a study of clinical features and relationships among circulating levels of calcium, parathyroid hormone and parathyroid hormone-related peptide.
Sriussadaporn S; Phoojaroenchanachai M; Ploybutr S; Plengvidhya N; Peerapatdit T; Nitiyanant W; Vannasaeng S; Vichayanrat A
J Med Assoc Thai; 2007 Apr; 90(4):663-71. PubMed ID: 17487119
[TBL] [Abstract][Full Text] [Related]
20. Urinary excretion of parathyroid hormone-related protein fragments in patients with humoral hypercalcemia of malignancy and hypercalcemic tumor-bearing nude mice.
Imamura H; Sato K; Shizume K; Satoh T; Kasono K; Ozawa M; Ohmura E; Tsushima T; Demura H
J Bone Miner Res; 1991 Jan; 6(1):77-84. PubMed ID: 2048434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
